Where: D18 |
[Show on Floor Plan] |
Sponsors of the: Respiratory Medicine Case Based Panel Session (Sat Hall 1a Session 2) and Advertising Sponsors
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.
Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavors.
In 2012, Boehringer Ingelheim
achieved net sales of about 14.7 billion euro, of which 22.5% of the net sales from our Prescription Medicine business is invested into research and development.
For more information please visit www.boehringer-ingelheim.co.uk.
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.
Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavors.
In 2012, Boehringer Ingelheim
achieved net sales of about 14.7 billion euro, of which 22.5% of the net sales from our Prescription Medicine business is invested into research and development.
For more information please visit www.boehringer-ingelheim.co.uk.
| Tel: | 01344 746 959 |
| Fax: | 01344 741349 |
| Address: | Ellesfield Avenue Bracknell Berkshire RG12 8YS |
| Website: | http://www.boehringer-ingelheim.co.uk |
| Email: | vetenquiries@bra.boehringer-ingelheim.com |